It is hypothesized that metformin may inhibit lymphoma cell oxidative metabolism or mTOR signaling, as DLBCL cells often have high PI3K/mTOR activity, enhancing chemo-induced apoptosis. This evidence concerns the gene MTOR and lymphoma.